Misonix to Report Fiscal 2019 Third Quarter Financial Results and Host Conference Call and Webcast on May 8
April 10 2019 - 8:04AM
Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a
provider of minimally invasive therapeutic ultrasonic medical
devices that enhance clinical outcomes, announced today that it
will report its fiscal 2019 third quarter financial results after
the market closes on Wednesday, May 8, 2019. The Company will host
a conference call and webcast at 4:30 p.m. ET that day to review
the results. Both the call and webcast are open to the general
public.
To access the conference call, interested
parties may dial 800/458-4121 (domestic) or 323/794-2093
(international) conference ID 2734632. Participants may also listen
to a live webcast of the call through the “Events and
Presentations” section under “Investor Relations” on Misonix’s
website at www.misonix.com. A webcast replay will be available for
30 days following the live event at www.misonix.com.
Please call five minutes in advance to ensure
that you are connected. Questions and answers will be taken only
from participants on the conference call. For the webcast, please
allow 15 minutes to register, download and install any necessary
software.
About Misonix, Inc.Misonix, Inc. (NASDAQ: MSON)
designs, develops, manufactures and markets ultrasonic medical
devices for the precise removal of hard and soft tissue, including
bone removal, wound debridement and ultrasonic aspiration. Misonix
is focused on leveraging its proprietary ultrasonic technology to
become the standard of care in operating rooms and clinics around
the world. Misonix's proprietary ultrasonic medical devices are
used in a growing number of medical procedures, including spine
surgery, neurosurgery, orthopedic surgery, cosmetic surgery,
laparoscopic surgery, and other surgical and medical applications.
At Misonix, Better Matters to us. That is why throughout the
Company’s history, Misonix has maintained its commitment to medical
technology innovation and the development of ultrasonic surgical
products that radically improve patient outcomes. Additional
information is available on the Company's web site at
www.misonix.com.
Contact: |
|
Joe
Dwye |
Joseph Jaffoni, Norberto Aja, Jennifer Neuman |
Chief Financial Officer |
JCIR |
Misonix, Inc. |
212-835-8500 or mson@jcir.com |
631-927-9113 |
|
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Aug 2024 to Sep 2024
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Sep 2023 to Sep 2024